mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0002 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0002 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0003 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
0.0004 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |